Barrett & Company’s CME Group CME Stock Holding History

Barrett & Company’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.5K	Hold	225	–	–	0.02%	256
2025 Q4	$61.4K	Hold	225	–	–	0.02%	269
2025 Q3	$60.8K	Hold	225	–	–	0.02%	272
2025 Q2	$62K	Hold	225	–	–	0.02%	270
2025 Q1	$59.7K	Hold	225	–	–	0.03%	245
2024 Q4	$52.3K	Hold	225	–	–	0.02%	265
2024 Q3	$49.6K	Sell	225 -280	-55%	-$57.9K	0.02%	266
2024 Q2	$99.2K	Buy	505 +1	+0.2%	+$207	0.04%	196
2024 Q1	$109K	Buy	504 +52	+12%	+$10.9K	0.05%	191
2023 Q4	$95.2K	Hold	452	–	–	0.05%	192
2023 Q3	$90.4K	Buy	452 +1	+0.2%	+$199	0.05%	187
2023 Q2	$83.6K	Hold	451	–	–	0.05%	204
2023 Q1	$86.3K	Buy	451 +17	+4%	+$3.07K	0.05%	194
2022 Q4	$73K	Hold	434	–	–	0.05%	201
2022 Q3	$73K	Buy	+434	New	+$85.8K	0.05%	201

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrett & Company's CME Position: Q1 2026 in Review

Barrett & Company held its CME Group (CME) position steady in Q1 2026 at 225 shares worth $66.5K. The position accounts for 0.02% of the portfolio, ranked #256.

Barrett & Company first reported a position in CME in Q3 2022 and has held it in 15 quarters since. The position peaked at $109K in Q1 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Barrett & Company held 225 shares of CME Group worth $66.5K as of Q1 2026.
Barrett & Company left its CME Group share count unchanged in Q1 2026.
CME Group made up 0.02% of Barrett & Company's portfolio in Q1 2026, its #256 holding.
Barrett & Company first reported a position in CME Group in Q3 2022 and has held it in 15 quarters since.
Barrett & Company's CME Group position peaked at $109K in Q1 2024.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.